Cutaneous vasculitis in systemic lupus erythematosus: epidemiology and risk factors over a 20-year follow-up

Systemic Lupus ErythematosusSystemic Sclerosis

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Rheumatology (Oxford)

Patasova K, Dehara M, Mantel Ä, Bixo M, Arkema E, Holmqvist M

doi: 10.1093/rheumatology/keaf004

Systemic Lupus Erythematosus

Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

Semin Arthritis Rheum

Choi MY, Guan H, Yoshida K, Paudel M, Kargere BA, Li D, Ellrodt J, Stevens E, Cai T, Weber BN, Everett BM, Costenbader KH

doi: 10.1016/j.semarthrit.2024.152468

Systemic Lupus Erythematosus

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study

Rheumatology (Oxford)

Ojeda-Fernandez L, Calvisi S, Torrigiani G, Tettamanti M, Fortino I, Roncaglioni C, Baviera M

doi: 10.1093/rheumatology/keae496

Further Publications Immunology

Risk of chronic kidney disease in 260 patients with lupus nephritis-analysis of a nationwide multicentre cohort with up to 35 years of follow-up

Rheumatology (Oxford)

Farinha F, Barreira S, Couto M, Cunha M, Fonseca D, Freitas R, Inês L, Luís M, Macieira C, Prata AR, Rodrigues J, Santos B, Torres R, Pepper RJ, Rahman A, Santos MJ

doi: 10.1093/rheumatology/keae236

Systemic Lupus Erythematosus

Risk of Diabetes Mellitus in systemic lupus erythematosus: systematic review and meta-analysis

Rheumatology (Oxford)

Etchegaray-Morales I, Mendoza-Pinto C, Munguía-Realpozo P, Solis-Poblano JC, Méndez-Martínez S, Ayón-Aguilar J, Abud-Mendoza C, García-Carrasco M, Cervera R

doi: 10.1093/rheumatology/keae204

Systemic Lupus Erythematosus

Association Between Antiphospholipid Antibodies and Diffuse Alveolar Hemorrhage Risk in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

Rheumatology (Oxford)

González-Treviño M, Figueroa-Parra G, Yang JX, Prokop LJ, Gamal SM, García MA, James JA, Knight JS, Murad MH, Narvaez J, Pons-Estel BA, Quintana RM, Specks U, Yang X, Duarte-García A

doi: 10.1093/rheumatology/keae632

Systemic Lupus Erythematosus

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Semin Arthritis Rheum

González LA, Harvey GB, Quintana R, Pons-Estel GJ, Ugarte-Gil MF, Vásquez G, Catoggio LJ, García MA, Borba EF, Da Silva NA, Brenol JCT, Toledano MG, Massardo L, Neira O, Pascual-Ramos V, Amigo MC, Barile-Fabris LA, Torre IG, Alfaro-Lozano J, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Iglesias-Gamarra A, Alarcón GS, Pons-Estel BA

doi: 10.1016/j.semarthrit.2024.152568

Osteoporosis

Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trial

EClinicalMedicine

Petersen TG, Abrahamsen B, Høiberg M, Rothmann MJ, Holmberg T, Gram J, Bech M, Åkesson KE, Javaid MK, Hermann AP, Rubin KH

doi: 10.1016/j.eclinm.2024.102584

Systemic Lupus Erythematosus

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Arthritis Care Res (Hoboken)

Sanchez-Rodriguez A, Meade-Aguilar JA, Yang JX, Figueroa-Parra G, Hanson AC, Langenfeld HE, Thanarajasingam U, Chamberlain AM, Greenlund KJ, Barbour KE, Crowson CS, Duarte-García A

doi: 10.1002/acr.25445

Related content

Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study

Risk of chronic kidney disease in 260 patients with lupus nephritis-analysis of a nationwide multicentre cohort with up to 35 years of follow-up

Risk of Diabetes Mellitus in systemic lupus erythematosus: systematic review and meta-analysis

Association Between Antiphospholipid Antibodies and Diffuse Alveolar Hemorrhage Risk in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trial

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)